Moxclav BD 228.5mg Powder for Oral Suspension

Moxclav BD 228.5mg Powder for Oral Suspension

Therapeutic Class:
Get Quote

In Treatment of Resistance Tuberculosis (TB) In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Moxclav BD 228.5mg Powder for Oral Suspension comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis. In Treatment of Bacterial infections Moxclav BD 228.5mg Powder for Oral Suspension contains two different medicines, Amoxycillin and Clavulanic Acid, that work together to kill the bacteria that cause infections. Amoxycillin works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Amoxycillin against bacteria. This combination medicine can be used to treat many different bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.

Salt Composition: Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
Strength: 200mg+28.5mg
Pack Size: bottle of 30 ml Powder for Oral Suspension
Uses: Treatment of Resistance Tuberculosis (TB) | Treatment of Bacterial infections
Table Header
Salt Composition
Amoxycillin (200mg) + Clavulanic Acid (28.5mg)
Strength
200mg+28.5mg
Pack Size
bottle of 30 ml Powder for Oral Suspension
Uses
Treatment of Resistance Tuberculosis (TB) | Treatment of Bacterial infections
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Moxclav BD 228.5mg Powder for Oral Suspension which is also known as Amoxycillin (200mg) + Clavulanic Acid (28.5mg) and Manufactured by Sun Pharmaceutical Industries Ltd. It is available in strength of Moxclav BD 228.5mg Powder for Oral Suspension is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Close Recently Viewed
Close
Close
Categories
error:
×